Marllor Biomedical

The Italian company Marllor Biomedical designs, develops and markets medical device technology and provides a technical contribution to the scientific leading non-surgical procedures in medicine and cosmetic dermatology, since 2007. Research and development are the primary objective of Marllor Biomedichal. The major investments are focused on clinical studies, quality and device registration.

Marllor Biomedichal is launching new products by integrating regulatory issues into all of its R&D activities from start to finish. The company has the total exclusive sale of Aqualyx®, the only device in the world indicated for the treatment of localized adiposity.